Tri-Institutional Therapeutics Discovery Institute
The Tri-Institutional Discovery Institute (Tri-I TDI) is a partnership between The Rockefeller University, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. Focusing on early-stage drug discovery, the Tri-I TDI provides expertise to researchers in medicinal chemistry and compound screening, and conducts "proof-of-concept" studies. The Institute also provides opportunities for training students and post-doctoral fellows, and enabling faculty to be involved in the drug discovery procees in order to support translational research.